{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:39:00Z","timestamp":1754109540961},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,24]]},"DOI":"10.7759\/cureus.38067","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T16:38:38Z","timestamp":1682354318000},"source":"Crossref","is-referenced-by-count":1,"title":["Common Coagulopathies Associated With COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Vinish","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshunna","family":"Keerti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-03029-y","article-title":"COVID-19-associated coagulopathy and disseminated intravascular coagulation","volume":"113","author":"Asakura H","year":"2021","unstructured":"Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021, 113:45-57. 10.1007\/s12185-020-03029-y","journal-title":"Int J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2020.100742","article-title":"Thrombosis and coagulopathy in COVID-19","volume":"46","author":"G\u00f3mez-Mesa JE","year":"2021","unstructured":"G\u00f3mez-Mesa JE, Galindo-Coral S, Montes MC, Mu\u00f1oz Martin AJ. Thrombosis and coagulopathy in COVID-19. Curr Probl Cardiol. 2021, 46:100742. 10.1016\/j.cpcardiol.2020.100742","journal-title":"Curr Probl Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000512007","article-title":"The impact of COVID-19 disease on platelets and coagulation","volume":"88","author":"Wool GD","year":"2021","unstructured":"Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021, 88:15-27. 10.1159\/000512007","journal-title":"Pathobiology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-00357-4","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","volume":"17","author":"Perico L","year":"2021","unstructured":"Perico L, Benigni A, Casiraghi F, Ng LF, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021, 17:46-64. 10.1038\/s41581-020-00357-4","journal-title":"Nat Rev Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba T","year":"2020","unstructured":"Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020, 18:2103-9. 10.1111\/jth.14975","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620938149","article-title":"COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation","volume":"26","author":"Miesbach W","year":"2020","unstructured":"Miesbach W, Makris M. COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost. 2020, 26:1076029620938149. 10.1177\/1076029620938149","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2020.04.004","article-title":"Clinical characteristics of coronavirus disease 2019 in China: Guan W, Ni Z, Hu Y, et al. N Engl J Med. 2020 Feb 28 [Online ahead of print] DOI: 10.1056\/NEJMoa2002032","volume":"58","author":"Eastin C","year":"2020","unstructured":"Eastin C, Eastin T. Clinical characteristics of coronavirus disease 2019 in China: Guan W, Ni Z, Hu Y, et al. N Engl J Med. 2020 Feb 28 [Online ahead of print] DOI: 10.1056\/NEJMoa2002032. J Emerg Med. 2020, 58:711-2. 10.1016\/j.jemermed.2020.04.004","journal-title":"J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi T","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P, et al.. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020, 588:315-20. 10.1038\/s41586-020-2700-3","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1150","article-title":"Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility","volume":"73","author":"Zhao J","year":"2021","unstructured":"Zhao J, Yang Y, Huang H, et al.. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021, 73:328-31. 10.1093\/cid\/ciaa1150","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang N","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020, 18:844-7. 10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-4. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose RJ","year":"2020","unstructured":"Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020, 8:e46-7. 10.1016\/S2213-2600(20)30216-2","journal-title":"Lancet Respir Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30376-5","article-title":"Prevention of the cytokine storm in COVID-19","volume":"21","author":"Wright DJ","year":"2021","unstructured":"Wright DJ. Prevention of the cytokine storm in COVID-19. Lancet Infect Dis. 2021, 21:25-6. 10.1016\/S1473-3099(20)30376-5","journal-title":"Lancet Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of coronavirus disease 2019","volume":"48","author":"Iba T","year":"2020","unstructured":"Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020, 48:1358-64. 10.1097\/CCM.0000000000004458","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","volume":"395","author":"Cummings MJ","year":"2020","unstructured":"Cummings MJ, Baldwin MR, Abrams D, et al.. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020, 395:1763-70. 10.1016\/S0140-6736(20)31189-2","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu C","year":"2020","unstructured":"Wu C, Chen X, Cai Y, et al.. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020, 180:934-43. 10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"Liao D","year":"2020","unstructured":"Liao D, Zhou F, Luo L, et al.. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020, 7:e671-8. 10.1016\/S2352-3026(20)30217-9","journal-title":"Lancet Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.57.397","article-title":"[Classifying types of DIC: clinical features and animal models]","volume":"57","author":"Asakura H","year":"2016","unstructured":"Asakura H. [Classifying types of DIC: clinical features and animal models]. Rinsho Ketsueki. 2016, 57:397-404. 10.11406\/rinketsu.57.397","journal-title":"Rinsho Ketsueki"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms J","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, et al.. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020, 46:1089-98. 10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox SE","year":"2020","unstructured":"Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020, 8:681-6. 10.1016\/S2213-2600(20)30243-5","journal-title":"Lancet Respir Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14980","article-title":"Lupus anticoagulant is frequent in patients with Covid-19: Response to reply","volume":"18","author":"Harzallah I","year":"2020","unstructured":"Harzallah I, Debliquis A, Dr\u00e9nou B. Lupus anticoagulant is frequent in patients with Covid-19: Response to reply. J Thromb Haemost. 2020, 18:E3-4. 10.1111\/jth.14980","journal-title":"J Thromb Haemost"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli B","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2950-73. 10.1016\/j.jacc.2020.04.031","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1300","article-title":"COVID-19 and coagulative axis: review of emerging aspects in a novel disease","volume":"90","author":"Boccia M","year":"2020","unstructured":"Boccia M, Aronne L, Celia B, et al.. COVID-19 and coagulative axis: review of emerging aspects in a novel disease. Monaldi Arch Chest Dis. 2020, 90:10.4081\/monaldi.2020.1300","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study","volume":"31","author":"Liu Y","year":"2020","unstructured":"Liu Y, Sun W, Guo Y, et al.. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020, 31:490-6. 10.1080\/09537104.2020.1754383","journal-title":"Platelets"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok FA","year":"2020","unstructured":"Klok FA, Kruip MJ, van der Meer NJ, et al.. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020, 191:145-7. 10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2450\/2020.0083-20","article-title":"COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)","volume":"18","author":"Marietta M","year":"2020","unstructured":"Marietta M, Ageno W, Artoni A, et al.. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020, 18:167-9. 10.2450\/2020.0083-20","journal-title":"Blood Transfus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko M","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020, 5:562-9. 10.1038\/s41564-020-0688-y","journal-title":"Nat Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan M","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJ, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020, 382:1653-9. 10.1056\/NEJMsr2005760","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp D","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, et al.. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020, 367:1260-3. 10.1126\/science.abb2507","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle D","year":"2020","unstructured":"McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020, 2:e437-45. 10.1016\/S2665-9913(20)30121-1","journal-title":"Lancet Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen KG","year":"2020","unstructured":"Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020, 26:450-2. 10.1038\/s41591-020-0820-9","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou P","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-3. 10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb7015","article-title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2","volume":"368","author":"Shi J","year":"2020","unstructured":"Shi J, Wen Z, Zhong G, et al.. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020, 368:1016-20. 10.1126\/science.abb7015","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang YZ","year":"2020","unstructured":"Zhang YZ, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020, 181:223-7. 10.1016\/j.cell.2020.03.035","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.05.023","article-title":"A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1\/S2 cleavage site of the spike protein","volume":"30","author":"Zhou H","year":"2020","unstructured":"Zhou H, Chen X, Hu T, et al.. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1\/S2 cleavage site of the spike protein. Curr Biol. 2020, 30:2196-2203.e3. 10.1016\/j.cub.2020.05.023","journal-title":"Curr Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 2020, 6:14. 10.1038\/s41421-020-0153-3","journal-title":"Cell Discov"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613397","article-title":"Viral hemorrhagic fever - a vascular disease?","volume":"89","author":"Schnittler HJ","year":"2003","unstructured":"Schnittler HJ, Feldmann H. Viral hemorrhagic fever - a vascular disease?. Thromb Haemost. 2003, 89:967-72. 10.1055\/s-0037-1613397","journal-title":"Thromb Haemost"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020712-164041","article-title":"Pathogenesis of the viral hemorrhagic fevers","volume":"8","author":"Paessler S","year":"2013","unstructured":"Paessler S, Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol. 2013, 8:411-40. 10.1146\/annurev-pathol-020712-164041","journal-title":"Annu Rev Pathol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.67","article-title":"Molecular mechanisms of Ebola virus pathogenesis: focus on cell death","volume":"22","author":"Falasca L","year":"2015","unstructured":"Falasca L, Agrati C, Petrosillo N, Di Caro A, Capobianchi MR, Ippolito G, Piacentini M. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ. 2015, 22:1250-9. 10.1038\/cdd.2015.67","journal-title":"Cell Death Differ"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","volume":"326","author":"Wong RS","year":"2003","unstructured":"Wong RS, Wu A, To KF, et al.. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003, 326:1358-62. 10.1136\/bmj.326.7403.1358","journal-title":"BMJ"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee N","year":"2003","unstructured":"Lee N, Hui D, Wu A, et al.. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003, 348:1986-94. 10.1056\/NEJMoa030685","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.5858\/2004-128-195-AODDTS","article-title":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis","volume":"128","author":"Chong PY","year":"2004","unstructured":"Chong PY, Chui P, Ling AE, et al.. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med. 2004, 128:195-204. 10.5858\/2004-128-195-AODDTS","journal-title":"Arch Pathol Lab Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit E","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016, 14:523-34. 10.1038\/nrmicro.2016.81","journal-title":"Nat Rev Microbiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.08.015","article-title":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses","volume":"100","author":"Hilgenfeld R","year":"2013","unstructured":"Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Res. 2013, 100:286-95. 10.1016\/j.antiviral.2013.08.015","journal-title":"Antiviral Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00512-20","article-title":"Laboratory diagnosis of COVID-19: current issues and challenges","volume":"58","author":"Tang YW","year":"2020","unstructured":"Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol. 2020, 58:10.1128\/JCM.00512-20","journal-title":"J Clin Microbiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang H","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020, 46:586-90. 10.1007\/s00134-020-05985-9","journal-title":"Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134991-common-coagulopathies-associated-with-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:34Z","timestamp":1707508834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134991-common-coagulopathies-associated-with-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.38067","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,24]]}}}